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1112-82 The Role of Myocardial Revascularization Surgery and 
Percutaneous Coronary Intervention in the Long-Term 
Follow-Up of Elderly Patients With Myocardial Infarction 
Jose C. Nicolaq Aenata T. Ladeira, Luciano M. Baracioli, Marcel0 Franker?, Luis F. 
Seguro, Jose Brum, Michael Sprafka, Jose A. Ramires. Heart Institute (InCor) - 
University of SBo Paula Medical School, SBo Paulo, Brazil 
Background: Little is known, especially in the elderly, about the role of surgical myocar- 
dial revascularization and percutaneous coronary intervention (invasive procedures - IP) 
in the long-term follow-up of pts with acute myocardial infarction (AMI), aim of this study. 
Methods: we analyzed 481 pts with AMI included prospectively and consecutively in a 
databank and followed for up to 4 years (mean survival time 3.15 y). During the in-hospi- 
tal phase, 309 pts were submitted to IP (64.2%). and 151 (31.4%) were older than 69 
years. Pearson Chi-square, Fisher exact test and Two-sample t-test ware utilized for the 
m-hospital analysis; Kaplan-M&r estimator, log-rank test and Cox proportional hazards 
regression were utilized in the long-term follow-up analysis. 
Results: (a) In-hospital analysis: for the elderly population, the mortality rate was 21.8%; 
the mortality rates for the subgroups submitted to IP @x=85) or treated conservatively 
were. respectively, 18.8% and 24.2% (O&0.78. ~~0.53); for pts younger than 70 y, the 
mortality rate was 5.5%; the mortality rates for the invasive (n=224) or conservative sub- 
groups were 6.2% and 4.7%, respectively (ORzl.35, p=O.58). (b) Long-term follow-up 
analysis: the unadjusted swwal rates for mvasive and conservative groups in the whole 
population were, respectively, 83.1% f 2.3 and 70.6% + 3.8 (p=O.O07); in the subgroup 
of pts older than 69 y the survival rates were 74.8% + 4.8 and 49.7% * 7, respectively 
(p=O.O35); in the subgroup of pts younger than 70 y, the sutvrval rates were 863% 4 2.5 
and 83.1% + 3.9 (p=O.7). Adjusted survival rates: 80 + 1.7 and 46.82 3.2 for the elderly 
population (p=O.O35); 87.2 -+ 1.3 and 82.5 + 2.0 for younger pts (p=O.7). SurvivalI rates 
excluding 83 pts treated with primary angioplasty: in the elderly group, 78.2 + 5.4 and 
49.7 + 7.0 (p=O.Ol I); in the younger group 86.8 -+ 2.8 and 83.1 + 3.9 (p=O.56). 
Concluston: in the long-term follow-up post-AMI. the invasive strategy was more effica- 
cious in elderly patients. 
1112-83 The Very Elderly (Over 80 Years) With Acute lschemic 
Syndromes Have Distinct Characteristics and 
Outcomes From Over 70 Years 
David A. Halon, Salim Adawi, ldit Med. Moshe Y. Flugelman, Basil S. Lewis, Lady Davis 
Carmel Medical Center, Haifa, Israel, Bruce Rappaport School of Medicine, Technion IIT. 
Haifa, Israel 
Background: Outcomes in elderly pts with acute ischemic syndromes (AIS) need inde- 
pendent analysis in order to define optimal treatment strategies. Even within this pt. 
group age may remain an important outcome predictor. We compared characteristics 
and outcomes in pts 70-79 and 280 yrs with AIS. 
Mathods: We studied 198 consecutive octogenarians (84.1+4.0 yr) and 251 consecutive 
septuagenarians (74.3~2.7 yr) with AIS. Pts were selected for coronary angiography and 
revascularization by clmical criteria and physician preference. Rehospitalization and 
symptomatic status were assessed at I+7 mths and survival at 24+3.5 mths. 
Results: Adverse baseline characteristics were more prevalent in pts 80+ yrs. Less had 
angio but greater proportion of these had revascularization (Table). 
Prevalence of Baseline Characteristm in Patients 7Ot and 80+ Years 
CHF AMI Renal failure(%) Coronary angio Revascularizati 
(%) (%) (creakl.5) 0 on 
% all % 
angio 
70+ 48 30 (12.3) 110 (43.8) 61 
Yrs (19.4) $7) (24.3) fi5.5) 
80+ 66 63 41 (21.6) 58 (29.3) 45 
Yrs (33.3) (35.0) (22.7) Tz7.6) 
P ,001 .OOOl .Oi ,002 “S ,005 
Mortality (65, 32.8% vs 40. 15.9%; p=.OOOl) and rehospitalization (106. 54% vs 112, 
45%; p=.O6) ware greater in pts 80+ yrs but survivors had greater symptomatic improve- 
ment at follow-up (84, 60.3% vs 96, 45.9%; p=.OO7). 
Conclusions: Major differencss exist in baseline characteristics and clinical outcomes in 
consecutive pts 70+ and 80+ yrs hospitalized for acute ischemic syndromes 2. Mortality 
was double and repeat hospitalization more frequent in pts 80+ but late symptomatic 
benefit was greater 3. Coronary angiography was performed less frequently in pts 80+ 
but more often lead to revascularization 4. Differences between 70+ and 80+ cohorts 
should be considered when analyzing outcomes of clinical trials in these age groups. 
1112-84 Sex Differences in Elderly Patients-Use of Coronary 
Revascularization After Acute Myocardial Infarction: A 
Tale of Two Therapies 
Saif S. Rathore. JoAnne M. Foody. Martha J. Radford. Diana L. Ordin, Harlan M. 
Krumholz, Yale University School of Medicine, New Haven, CT, Centers for Medicare 8 
Medicaid Services, Boston, MA 
Background: Prior studies have repotted conflicting findings concerning sex differences 
in coronary revascularization use after cardiac cathetenzation among patients hospital- 
ized with acute myocardial infarction (MI). The extent to which sex differences in coro- 
nary revascularization use vary by type of revascularization therapy is unclear. 
Methods: We evaluated patients from the Cooperative Cardiovascular Project. a set of 
Medicare beneficiaries hospitalized for Ml between 1994-1996, to determine if women 
were less likely than men to undergo coronary revascularization post-MI. Patients 65 
years of age or older not transferred in to the hospital who had undergone cardiac cathe- 
terization post-MI (n=66,830) were evaluated for the use of percutaneous coronary inter- 
ventions (PCI) or coronary artery bypass surgery (CABG) wtthin 60 days of Ml. 
Multivariable logistic regression analyses were used to derive risk-standardized rates for 
the use of any coronary revascularization, revasculartzation by CABG, and revascular- 
ization by PCI after adjusting for patient sociodemographic and clinical factors, physician 
characteristics, and hospital type. 
Results: Women had lower crude rates of overall coronary revascularization than men 
(65.2% vs. 68.7%. p<O.OOl). Sex differences in revasculanzation use, however, varied 
by type of revascularization therapy. Women had lower rates of CABG use than men 
(28.6% vs. 33.2%, p<O.OOl), but higher rates of PC use than men (41.4% vs. 38.5%. 
pcO.001). Multivariable adjustment reduced the sex difference in overall coronary revas- 
culartzation use from 3.5% to 2.1% (66.0% women vs. 68.1% men, p<O.OOl). Women 
had lower risk-standardized rates of CABG use (27.3% vs. 33.3%, p<O.OOl), but higher 
risk-standardized rates of PCI use (42.0% vs. 38.2%, p<O.OOl) than men. 
Conclusion: Sex differences in coronary revascularization use among elderly patients 
post-MI vary by revascularization strategy with women less likely to undergo CAEG, but 
more likely to undergo PCI than man. 
1112-85 The Effect of Age on Early Death and Stroke Rates in 
Patients With Heart Failure After Acute Myocardial 
Infarction 
Harvev D. White Philip E. Aylward. Anthony Dalby, W. Douglas Weaver, Karl Swedberg. 
Stale Barvik, Jose Mann-Neto, Jan Murin, Rolf Norlander, Wiek H. van Gilst, Faiez 
Zannad, Green Lane Hospital, Auckland, New Zealand 
Background: Most trials of patients with heart failure following myocardial infarction 
have not enrolled a representative population, with many elderly patients being excluded. 
Methods: In the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial, in which 
patients had hearl failure and/or a left ventricular ejection fraction of ~40%. 3,189 
patients (21.5%) were aged 275 years. We evaluated the effect of demographics and 
outcomes at 30 days in pattents aged ~75 and 2775 years. 
Results: Compared with younger patients, elderly patients were more likely to have 
high-risk demographics. However, their ejection fractions were similar. Older patients 
were less frequently treated with aspirin, kblockers, or reperfusion therapy. On multivari- 
able analysts, including all baseline variables, age was an mdependent predictor of 30. 
day mortality, with each IO-year increase in age being associated with a 50% increase in 
30-day mortality (hazard ratio 1.47. 1.35 - 1.60). 
Conclusion Despite high b-blocker and ACE inhibitor and/or angiotensln receptor 
blockade usage in all patients (the drugs being tested in VALIANT), outcomes remain 
less than ideal in very elderly patients. More effective therapies are required to improve 
survival and decrease the incidence of stroke in this important and increasingcohort. 
Female sex 
Body mass index 
Killip class Ill 
Killip class IV 
Renal insufficiency 
Diabetes 
Hypertension 
Prior Ml 
Prior CVA 
Ejection fraction 
Heart rate, beats/mm 
Systolic BP, mmHg 
Aspirin 
Beta blockers 
Thrombolysis 
Primary angioplasty 
Death 
Stroke 
Death or stroke 
Age ~75 
“= 11,615 
26.7% 
28.3 
16.3% 
5.8% 
3.6% 
22.9% 
53.3% 
26.5% 
5.3% 
34.8% 
76.4 
121.8 
89.9% 
72.2% 
37.6% 
16.5% 
3.2% 
0.7% 
3.7% 
Age 2775 
n = 3,189 
47.3% 
26.6 
21.4% 
8.2% 
7.0% 
23.7% 
61.6% 
33.1% 
9.1% 
34.5% 
75.7 
125.8 
85.8% 
63.0% 
25.4% 
9.6% 
7.2% 
1.2% 
8.0% 
P value 
<0.0001 
co.ooo1 
<0.0001 
<0.0001 
<0.0001 
0.3573 
<0.0001 
<0.0001 
<0.0001 
0.1556 
0.0198 
<0.0001 
<0.0001 
<0.0001 
<0.0001 
<0.0001 
<0.0001 
0.008 
<0.0001 
